<DOC>
	<DOCNO>NCT01437189</DOCNO>
	<brief_summary>The aim open-label , self-control study evaluate efficacy sertraline treat depression Patients Parkinson 's disease . In addition , investigator also want find whether patient get good quality life depression improve .</brief_summary>
	<brief_title>The Effects Sertraline Depression Parkinson 's Disease</brief_title>
	<detailed_description>Depression PD associate severe cognitive functional impairment , fast progression illness , bad quality life , increase mortality high burden caregiver , compare PD patient without depression . Depression account approximately 40-50 % PD patient , also well know main factor impact health-related quality life ( HRQoL ) negative way context PD even caregiver . In previous cross-sectional study , investigator already study prevalence depressive symptom PD patient also prove depressive symptom severely worsen HRQoL PD patient area mainland China . In order improve HRQoL PD , intervention , example , take antidepressant improve depression urgently require . In addition , investigator already test validity reliability Chinese version 39-item Parkinson 's disease questionnaire ( PDQ-39 ) mainland China , paper already publish journal Zhejiang university science B ( biomedicine biotechnology ) already , therefore , investigator use questionnaire Chinese version PDQ-39 ass PD patient ' quality life . Treatment depression antidepressant drug well establish . In last 20 year , application antidepressant risen mainly due introduction selective serotonin reuptake inhibitor ( SSRIs ) . These drug commonly prescribe antidepressant patient depression general . Regarding depression context PD , recent survey U.S. show 63 % prescription depression PD SSRIs 7.5 % tricyclic antidepressant ( TCAs ) . The preference SSRIs old TCAs supposedly base similar efficacy well tolerability , especially compare tertiary amine , amitriptyline imipramine . Sertraline characterize low selectivity serotonin relative dopamine reuptake , suggest favorable efficacy profile . There randomize study point sertraline low-dose amitriptyline improve depressive symptom PD , significant benefit quality life observe sertraline . Still , study need demonstrate whether sertraline effective depression PD patient . Further , trial efficacy safety sertraline depression PD mainland China . It 's necessary u initiate conduct trial mainland China .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>1 . Patients 35 75 year age outpatients clinic Department Neurology , Second Affiliated Hospital , School Medicine , Zhejiang University . 2 . All patient confirm diagnosis PD accord Brain Bank Criteria . 3 . Diagnosed major depression episode accord DSMIV , 4 . Mini Mental State Examination ( MMSE ) exclude dementia . 1 . MiniMental State Examination ( MMSE ) demonstrate dementia 2 . Any current DSMIV Axis I diagnosis depressive anxiety disorder . 3 . History psychosis hallucination treatment atypical neuroleptic . 4 . Treatmentresistant depression . Treatmentresistant depression ( TRD ) occur patient unipolar depression fail respond adequate antidepressant therapy . 5 . Pregnancy lactation . 6 . Concomitant use patient take monoamine oxidase inhibitor ( MAOIs ) . 7 . Concomitant use patient take pimozide .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>depression</keyword>
	<keyword>sertraline</keyword>
	<keyword>intervention</keyword>
</DOC>